StockrabitBrowse analysts
Analyst questions

Pankaj Tibrewal

Firm not listed in source transcripts
MANKIND

Mankind Pharma Limited

All company calls
Mankind Pharma Limited
30 Jul 2026
Open call
  1. Yes. Thank you. This is Pankaj Tibrewal from Ikigai Asset Manager. Am I audible?

    Read in transcript
  2. Okay. Just from an India business perspective, just wanted to get a sense that always, we have talked about India business growing at 1.2x to 1.3x the IPM growth. Last year was obviously not a great year. And this year also, the start has not been as great because the IPM itself, the market has been very, very strong. How do you foresee the remainin g 9 months for this year from an India growth perspective?

    Read in transcript
  3. So in terms of -- can we here -- from here on, expect Mankind to consistently outperform IPM with this field force change, everything we have done and all the long-term drivers we are talking about? Is it a fair expectation?

    Read in transcript
+3 more questions in this call